Engitix Therapeutics
0 followers
‌
To create a healthier future for patients with life-threatening diseases, Engitix Therapeutics is using its pioneering human extracellular matrix (ECM)-based discovery platform to develop a portfolio of programmes in fibrosis and solid tumors.
Industries
Headquarters
Employees
Links
Org chart
Giuseppe Mazza
CEO & Co-Founder
Giuseppe Mazza
Collapse
Chris Stevenson
Chief Scientific Officer
Alan Holmes
Vice President Fibrosis
Thomas Gobbetti
Liver Fibrosis Progamme Leader And Director Of Translational Biology / In Vivo
Lisa Longato
Director Biology
Amélie Fortin
Director, People & Culture
Calum MacLeod
Director Of Medicinal Chemistry
Luca Frenguelli
Director of Biomaterials
Amy Lewis
Director, Fibrosis
Athiva Shankar
Associate Director, Biospecimens & Tissue-Based Assays
Simran Sagoo
Accountant
